Research Papers

25 of 121 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
How Will Our Practice Change After the CLEAR Outcomes Trial?
Abrahams T; Nelson AJ; Nicholls SJ.
Curr Atheroscler Rep (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Lipoprotein(a): from Causality to Treatment.
Kronenberg F.
Curr Atheroscler Rep (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?
Surma S; Sahebkar A; Banach M.
Curr Atheroscler Rep (Unknown)
Published: 2024
2/6 Transparent
Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes.
Zhu J; Wilding JPH.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
Kastelein JJP; Hsieh A; Dicklin MR; Ditmarsch M; Davidson MH.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Natural Sirtuin1 Activators and Atherosclerosis: an Overview.
Łanoszka K; Vlčková N.
Curr Atheroscler Rep (Unknown)
Published: 2023
2/6 Transparent
Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagn…
Larrea-Sebal A; Jebari-Benslaiman S; Galicia-Garcia U; Jose-Urteaga AS; Uribe KB; Benito-Vicente A; Martín C.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Sex Differences in Familial Hypercholesterolemia.
Klevmoen M; Mulder JWCM; Roeters van Lennep JE; Holven KB.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Percutaneous Coronary Interventions in Women.
Joodi G; Palimar S; Press MC.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Statin Use and Coronary Artery Calcification: a Systematic Review and Meta-analysis of Observational Studies and Random…
Shahraki MN; Jouabadi SM; Bos D; Stricker BH; Ahmadizar F.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Registered
Updates in Small Interfering RNA for the Treatment of Dyslipidemias.
Carugo S; Sirtori CR; Gelpi G; Corsini A; Tokgozoglu L; Ruscica M.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Precision Nutrition and Cardiovascular Disease Risk Reduction: the Promise of High-Density Lipoproteins.
Hong BV; Agus JK; Tang X; Zheng JJ; Romo EZ; Lei S; Zivkovic AM.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Invasive Coronary Assessment in Myocardial Ischemia with No Obstructive Coronary Arteries.
Takahashi T; Gupta A; Samuels BA; Wei J.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis.
Francis GA.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Updates in Drug Treatment of Severe Hypertriglyceridemia.
Gouni-Berthold I; Schwarz J; Berthold HK.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Pandemic of Coronary Heart Disease in the Middle East and North Africa: What Clinicians Need to Know.
Manla Y; Almahmeed W.
Curr Atheroscler Rep (Unknown)
Published: 2023
2/6 Transparent
Hypertension and Dyslipidemia: the Two Partners in Endothelium-Related Crime.
Dąbrowska E; Narkiewicz K.
Curr Atheroscler Rep (Unknown)
Published: 2023
2/6 Transparent
Statin Intolerance: an Overview of US and International Guidance.
Cheeley MK; Clegg K; Lockridge C; Schubert TJ; Jones LK.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Medical Nutrition Therapy Provided by Dietitians is Effective and Saves Healthcare Costs in the Management of Adults wi…
Sikand G; Handu D; Rozga M; de Waal D; Wong ND.
Curr Atheroscler Rep (Unknown)
Published: 2023
2/6 Transparent
The Role of Cardiac PET in Diagnosis and Prognosis of Ischemic Heart Disease: Optimal Modality Across Different Patient…
Nayfeh M; Ahmed AI; Saad JM; Alahdab F; Al-Mallah M.
Curr Atheroscler Rep (Unknown)
Published: 2023
2/6 Transparent
Importance of Nutrition Security to CVD Prevention Efforts in the USA.
Cheng J; Malone A; Thorndike AN.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Coconut Oil and Cardiovascular Disease Risk.
Schwingshackl L; Schlesinger S.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Brief Review: Racial and Ethnic Disparities in Cardiovascular Care with a Focus on Congenital Heart Disease and Precisi…
Bayne J; Garry J; Albert MA.
Curr Atheroscler Rep (Unknown)
Published: 2023
2/6 Transparent
Structure-based mechanism and inhibition of cholesteryl ester transfer protein.
Xue H; Zhang M; Liu J; Wang J; Ren G.
Curr Atheroscler Rep (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Genetic Testing in Familial Hypercholesterolemia: Is It for Everyone?
Medeiros AM; Bourbon M.
Curr Atheroscler Rep (Unknown)
Published: 2023
3/6 Transparent
Funding Declared